UnitedHealthcare

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been delayed until January to allow his lawyers to focus on his state murder trial starting in September. Mangione arrived late to a court hearing due to an elevator malfunction, marking the second recent delay in his court appearances.

Luigi Mangione’s federal trial was postponed to January to avoid overlapping with his state court trial starting in September. The judge cited scheduling conflicts and challenges in conducting jury selection amid media attention and dual proceedings. Mangione faces murder and weapons charges in state court and stalking in federal court for the December 2024 killing of UnitedHealthcare CEO Brian Thompson.

Luigi Mangione’s federal trial in the killing of UnitedHealthcare CEO Brian Thompson has been postponed until January by a judge.

Luigi Mangione’s federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January to allow his lawyers to focus on his state murder trial starting in September. The federal trial’s jury selection will begin on January 5, with opening statements on January 25, as Judge Margaret Garnett cited the impossibility of conducting jury selection while Mangione’s team handles the state case.

Luigi Mangione’s federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January by U.S. District Judge Margaret Garnett to allow his lawyers to focus on his state murder trial.

A federal judge in Lower Manhattan has set the trial date for Luigi Mangione, who is accused of fatally shooting UnitedHealthcare CEO Brian Thompson. The trial is scheduled for January 2027.

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January. Mangione, 28, pleaded not guilty to federal stalking charges during a hearing in New York City on February 21, 2025.

Luigi Mangione, 28, is scheduled to appear in federal court for a pretrial hearing and faces state and federal charges related to the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel. Mangione has pleaded not guilty to the charges.

Luigi Mangione, 28, is set to appear in federal court for a pretrial hearing and has pleaded not guilty to state and federal charges related to the December 2024 shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione, 28, has pleaded not guilty to state and federal charges related to the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione, 28, has pleaded not guilty to both state and federal charges stemming from the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione's pretrial hearing for federal charges related to the shooting death of UnitedHealthcare CEO Brian Thompson is scheduled for Monday at Manhattan Federal Court. Mangione pleaded not guilty to state and federal charges in the case.

A deadlocked jury in the Palisades Fire case has raised concerns about ideological influences in jury decisions, with fears that similar issues could affect Luigi Mangione's trial. Jonathan Rinderknecht, accused of causing the fire, received a mistrial after jurors split 10-2, and a retrial is planned. Former prosecutor Neama Rahmani warns that public sympathy for Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, could lead to jury nullification.

Luigi Mangione's attorneys claim federal prosecutors violated his rights. Mangione faces state and federal charges for UnitedHealthcare CEO Brian Thompson's murder in December 2024 and has pleaded not guilty in both cases.

Luigi Mangione's defense team initially raised an 'extreme emotional disturbance' defense for his murder trial but later withdrew it. The defense claimed the legal strategy could reduce murder charges to manslaughter under New York law, though it requires the defendant to prove emotional distress triggered the killing.

Cadence, a digital health company, raised $100 million in funding led by Spark Capital, valuing the company at $1.23 billion. The investment aims to expand Cadence's chronic disease management programs and automate clinician work with AI, despite scrutiny over its billing model from the federal health department's watchdog and insurers like UnitedHealthcare.

Luigi Mangione withdrew a planned psychiatric defense in the murder trial of UnitedHealthcare CEO Brian Thompson, likely due to concerns about federal charges. The defense could have reduced his state murder charge to manslaughter but may have jeopardized his federal case, which has no equivalent legal protection.

Lawyers for Luigi Mangione have withdrawn their plan to pursue a psychiatric defense in his New York state murder trial over the killing of UnitedHealthcare CEO Brian Thompson. The decision is analyzed by CBS News legal contributor Jessica Levinson.

Luigi Mangione's lawyers are withdrawing a psychiatric defense for his New York state murder trial. The judge had previously indicated Mangione would claim extreme emotional disturbance during the alleged killing of UnitedHealthcare CEO Brian Thompson.

David Cordani is stepping down as Cigna CEO after 17 years, during which the company's revenue grew from $18 billion to $275 billion. He attributed the recent public distrust in health insurers to rising healthcare costs and responded by launching Cigna's 'Commitments to Better' initiative to rebuild trust. The December 2024 shooting of UnitedHealthcare CEO Brian Thompson heightened industry tensions, prompting Cigna to prioritize active listening to address societal concerns.

Luigi Mangione's lawyers announced a reversal, stating he will no longer use a psychiatric defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. The decision was made during a court appearance on Thursday.

Luigi Mangione's legal team abandoned a psychiatric defense in his state murder trial. He is accused of killing UnitedHealthcare CEO Brian Thompson. CBS News legal reporter Katrina Kaufman provided details.

Luigi Mangione dropped his mental health defense in the Manhattan murder case involving UnitedHealthcare CEO Brian Thompson. Court records initially set to be unsealed will now remain sealed.

Luigi Mangione's legal team reversed their decision to use a psychiatric defense in his trial for the killing of UnitedHealthcare CEO Brian Thompson. The defense initially claimed Mangione was under 'extreme emotional disturbance' at the time of the 4 December 2024 murder.

Luigi Mangione's legal team abandoned a psychiatric defense in his trial for the killing of UnitedHealthcare CEO Brian Thompson after just one day. The defense had initially claimed Mangione was under 'extreme emotional disturbance' at the time of the 4 December 2024 shooting.

Luigi Mangione withdrew his psychiatric defense in the UnitedHealthcare CEO assassination case, per court filings, with no explanation provided. The judge maintained sealed records from prior proceedings, and the move shifts the trial's potential legal strategy away from an 'extreme emotional disturbance' defense. Mangione faces state and federal charges and is scheduled for trial in September.

Luigi Mangione’s lawyers withdrew their planned psychiatric defense for his state murder trial, reversing a prior decision. The defense had aimed to claim extreme emotional disturbance at the time of the 2024 killing of UnitedHealthcare CEO Brian Thompson, which could have led to a manslaughter conviction. Mangione’s state trial begins Sept. 8, with a federal trial following on Oct. 13.

Luigi Mangione's lawyers reversed their decision to pursue a psychiatric defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. They withdrew the extreme emotional disturbance claim, which could have reduced his potential sentence from murder to manslaughter. The trial is scheduled to begin on September 8.

Luigi Mangione abruptly withdrew his planned 'extreme emotional disturbance' psychiatric defense for the trial in the killing of UnitedHealthcare CEO Brian Thompson. The defense was scrapped one day after being filed.

Luigi Mangione is using an 'extreme emotional disturbance' defense in his murder trial for killing UnitedHealthcare CEO Brian Thompson, linking his actions to his criticism of the U.S. healthcare system. The defense could reduce his charge from second-degree murder to first-degree manslaughter if successful.

The Supreme Court is set to release rulings on birthright citizenship and Temporary Protected Status (TPS) for Haitian and Syrian immigrants as part of Donald Trump’s immigration agenda. Additional cases include a psychiatric defense in the Manhattan trial of Luigi Mangione over the killing of UnitedHealthcare executive Brian Thompson.

Luigi Mangione will use an extreme emotional disturbance defense in his state murder trial for killing UnitedHealthcare CEO Brian Thompson, which could result in a manslaughter conviction with up to 25 years in prison instead of a potential life sentence for murder. Judge Gregory Carro confirmed the defense strategy, which is not available in Mangione's separate federal trial, and stated the state trial is set to begin on September 8.

Luigi Mangione plans to use a psychiatric defense in his state murder trial for killing UnitedHealthcare CEO Brian Thompson, which could reduce his charge to manslaughter with a maximum 25-year sentence. The defense is not available in his federal case, where he faces a potential life sentence.

Luigi Mangione will use an 'extreme emotional disturbance' defense at his New York murder trial for the 2024 killing of UnitedHealthcare CEO Brian Thompson. The defense could reduce his charge from murder to manslaughter if successful, with the judge ordering the defense to disclose their psychiatric expert and specific mental defect by a deadline.

Luigi Mangione's lawyers plan to use a psychiatric defense in his New York State murder trial for the killing of UnitedHealthcare CEO Brian Thompson.

Luigi Mangione will use a psychiatric defense in his state murder trial for killing UnitedHealthcare CEO Brian Thompson, arguing he was under extreme emotional disturbance. A jury could convict him of manslaughter instead of murder if they accept the defense, while his federal case remains unaffected by this strategy.

Luigi Mangione will use a psychiatric defense in his state trial for the murder of UnitedHealthcare CEO Brian Thompson, as announced by a Manhattan judge during a court hearing. The defense strategy was disclosed in a bombshell court session on Wednesday.

Luigi Mangione appeared in Manhattan state court on Wednesday after missing an earlier court date due to a paperwork error. He faces nine counts, including second-degree murder, related to the December 2024 killing of UnitedHealthcare CEO Brian Thompson in New York City.

Luigi Mangione will use a psychiatric defense in his state murder trial for killing UnitedHealthcare CEO Brian Thompson. Judge Gregory Carro confirmed the defense's plan to argue extreme emotional disturbance at the time of the shooting, which could result in psychiatric treatment instead of prison. Mangione's state trial is set for Sept. 8, and his federal trial for stalking charges begins on Oct. 13.

Luigi Mangione will assert a psychiatric defense in his state murder trial for the killing of UnitedHealthcare CEO Brian Thompson. A judge allowed the defense, which could result in psychiatric treatment instead of prison, with trials set for September and October. Evidence includes a 3D-printed pistol and a notebook detailing plans to target a health insurance executive.